Risk of detrimental recommendations for cancer pain management.
作者信息
Maltoni Marco, Rossi Romina
机构信息
Palliative Care Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura Dei Tumori (IRST) IRCCS, via P. Maroncelli 40, Meldola, FC, Italy.
出版信息
J Transl Med. 2021 Apr 20;19(1):160. doi: 10.1186/s12967-021-02831-4.
Abstract
摘要
相似文献
1
Risk of detrimental recommendations for cancer pain management.癌症疼痛管理不当建议的风险。
J Transl Med. 2021 Apr 20;19(1):160. doi: 10.1186/s12967-021-02831-4.
2
The challenges of cancer pain assessment and management.癌症疼痛评估与管理的挑战。
Ulster Med J. 2013 Jan;82(1):40-2.
3
The challenges of cancer pain assessment and management.癌症疼痛评估与管理的挑战。
Ulster Med J. 2012 May;81(2):100-1.
4
The challenges of cancer pain assessment and management.癌症疼痛评估与管理的挑战。
Ulster Med J. 2011 May;80(2):104-6.
5
Cancer pain.癌痛
JAMA. 2003 Nov 12;290(18):2476-9. doi: 10.1001/jama.290.18.2476.
6
Pain intensity and pain management of hospitalized patients with cancer: an opportunity for improvement.
Clin J Oncol Nurs. 2013 Aug 1;17(4):365-8. doi: 10.1188/13.CJON.365-368.
7
The challenges of cancer pain assessment.癌症疼痛评估的挑战。
Ulster Med J. 2014 Jan;83(1):44-6.
8
Cancer pain--progress and ongoing issues in the United States.癌症疼痛——美国的进展与现存问题
Pain Res Manag. 2009 Sep-Oct;14(5):363-4.
9
Has pain management improved over the last decade in the Rapid Response Radiotherapy Program?在快速反应放射治疗项目中，疼痛管理在过去十年里有所改善吗？
Curr Opin Support Palliat Care. 2016 Mar;10(1):3-4. doi: 10.1097/SPC.0000000000000192.
10
Pain management principles.疼痛管理原则。
Curr Probl Cancer. 2011 Nov-Dec;35(6):317-24. doi: 10.1016/j.currproblcancer.2011.10.006.
引用本文的文献
1
Development of a predictive model for patients with bone metastases referred to palliative radiotherapy: Secondary analysis of a multicenter study (the PRAIS trial).开发一种用于接受姑息性放疗的骨转移患者的预测模型：一项多中心研究（PRAIS 试验）的二次分析。
Cancer Med. 2024 Oct;13(19):e70050. doi: 10.1002/cam4.70050.
2
Risk of confounding variables in multivariate analysis.多变量分析中混杂变量的风险。
J Transl Med. 2022 Apr 9;20(1):165. doi: 10.1186/s12967-022-03348-0.
本文引用的文献
1
The role of opioids in cancer response to immunotherapy.阿片类药物在癌症免疫治疗反应中的作用。
J Transl Med. 2021 Mar 23;19(1):119. doi: 10.1186/s12967-021-02784-8.
2
Risk factors for aspiration pneumonia during concurrent chemoradiotherapy or bio-radiotherapy for head and neck cancer.头颈部癌症同期放化疗或生物放疗期间吸入性肺炎的危险因素。
BMC Cancer. 2020 Mar 4;20(1):182. doi: 10.1186/s12885-020-6682-1.
3
The prognostic and predictive role of pain before systemic chemotherapy in recurrent ovarian cancer: an individual participant data meta-analysis of the North-Eastern German Society of Gynecological Oncology (NOGGO) of 1226 patients.在复发性卵巢癌中，全身化疗前疼痛的预后和预测作用：来自东北德国妇科肿瘤学会（NOGGO）的 1226 名患者的个体参与者数据荟萃分析。
Support Care Cancer. 2020 Apr;28(4):1997-2003. doi: 10.1007/s00520-019-05000-y. Epub 2019 Aug 5.
4
A systematic review of the impact of pain on overall survival in patients with cancer.一项关于疼痛对癌症患者总生存期影响的系统评价。
Support Care Cancer. 2017 May;25(5):1687-1698. doi: 10.1007/s00520-017-3614-y. Epub 2017 Feb 11.
5
Effects of opioids on immunologic parameters that are relevant to anti-tumour immune potential in patients with cancer: a systematic literature review.阿片类药物对癌症患者与抗肿瘤免疫潜能相关的免疫参数的影响：系统文献回顾。
Br J Cancer. 2014 Aug 26;111(5):866-73. doi: 10.1038/bjc.2014.384. Epub 2014 Jul 15.
6
Epidemiology of infections in cancer patients.癌症患者感染的流行病学
Cancer Treat Res. 2014;161:43-89. doi: 10.1007/978-3-319-04220-6_2.
7
Predicting survival in patients with advanced disease.预测晚期疾病患者的生存率。
Eur J Cancer. 2008 May;44(8):1146-56. doi: 10.1016/j.ejca.2008.02.030. Epub 2008 Apr 3.
8
Prognostic factors in advanced cancer patients: evidence-based clinical recommendations--a study by the Steering Committee of the European Association for Palliative Care.晚期癌症患者的预后因素：循证临床建议——欧洲姑息治疗协会指导委员会的一项研究
J Clin Oncol. 2005 Sep 1;23(25):6240-8. doi: 10.1200/JCO.2005.06.866.
9
The immune-suppressive effects of pain.
Adv Exp Med Biol. 2003;521:117-25.
Zotero 插件